These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent developments in the clinical application of thyroid cancer biomarkers. Shibru D; Chung KW; Kebebew E Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251 [TBL] [Abstract][Full Text] [Related]
3. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Eszlinger M; Paschke R Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis of thyroid cancer: state of art. Boufraqech M; Patel D; Xiong Y; Kebebew E Expert Opin Med Diagn; 2013 Jul; 7(4):331-42. PubMed ID: 23701167 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Kebebew E; Peng M; Reiff E; McMillan A Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775 [TBL] [Abstract][Full Text] [Related]
6. An update on molecular biology of thyroid cancers. Omur O; Baran Y Crit Rev Oncol Hematol; 2014 Jun; 90(3):233-52. PubMed ID: 24405857 [TBL] [Abstract][Full Text] [Related]
7. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients. Cañadas-Garre M; Becerra-Massare P; López de la Torre-Casares M; Villar-del Moral J; Céspedes-Mas S; Vílchez-Joya R; Muros-de Fuentes T; García-Calvente C; Piédrola-Maroto G; López-Nevot MA; Montes-Ramírez R; Llamas-Elvira JM Ann Surg; 2012 May; 255(5):986-92. PubMed ID: 22504197 [TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of BRAFV600E and RET/PTC oncogenes in thyroid nodule aspirates]. Guerra A; Carrano M; Angrisani E; Vitale M Recenti Prog Med; 2013; 104(7-8):415-9. PubMed ID: 24042420 [TBL] [Abstract][Full Text] [Related]
9. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. Rossi ED; Martini M; Capodimonti S; Lombardi CP; Pontecorvi A; Vellone VG; Zannoni GF; Larocca LM; Fadda G Cancer Cytopathol; 2013 Jun; 121(6):291-7. PubMed ID: 23192956 [TBL] [Abstract][Full Text] [Related]
10. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms? Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512 [TBL] [Abstract][Full Text] [Related]
11. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693 [TBL] [Abstract][Full Text] [Related]